Clinical Trial Update: Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants [Phase 1]

View source ↗

Summary

This Phase 1 study assessed the local nasal tolerability and safety of the investigational agent 1146A in healthy adult participants and has been completed. Gla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• 1146A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Common Cold | Phase 1 | Status: COMPLETED